Adicet Bio, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Adicet Bio, Inc. (formerly resTORbio, Inc.) on July 19, 2021. The report discloses the entry into a material definitive agreement regarding the sublease of the Company's principal executive offices located at 500 Boylston Street, Boston, Massachusetts.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. The specific financial terms disclosed relate solely to the sublease transaction:
- Sublease Revenue: Approximately $3.5 million in aggregate base rent.
- Security Deposit: Approximately $115,595 in cash received upon execution.
- Asset Transfer: Furniture transferred to the sublessee for $1.00.
Material Changes
The primary material change is the agreement to sublease 9,501 rentable square feet of office space to RFS OPCO LLC. This transaction is contingent upon landlord approval, which is expected by August 1, 2021. If approved, the sublease term will run from September 1, 2021, through July 30, 2026.
Outlook, Risks, and Contingencies
The effectiveness of the sublease agreement is subject to the approval of the landlord (500 Boylston & 222 Berkeley Owner (DE) LLC). The filing notes that the sublease term is also subject to earlier termination if the underlying Master Lease is terminated. The Company is obligated to return the security deposit within 60 days of the sublease expiration or early termination, provided the sublessee is not in default.
Key Facts for Investor Verification
- Confirmation of landlord approval for the sublease by August 1, 2021.
- Impact of the sublease on the Company's future operating expense structure.
- Details regarding the remaining term and obligations of the Master Lease.